Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

Artificial Intelligence augmenting Medical Management Scientific Programme
Year: 2019
Authors: Geert Meyfroidt
Assessing and grading postoperative recurrence6th ECCO-ESGAR Ultrasound Workshop - Advanced
Year: 2019
Authors: Stephan Vavricka
Assessing bowel damage in CD from adult to childhoodScientific Programme
Year: 2019
Authors: Anne Griffiths
Best practice in screening for dysplasiaScientific Programme
Year: 2019
Authors: Marietta Iacucci
Breastfeeding and risk of IBD4th D-ECCO Workshop
Year: 2019
Authors: Joana Torres
Can we cure IBD?Scientific Programme
Year: 2019
Authors: Arthur Kaser
Can we prevent IBD?Scientific Programme
Year: 2019
Authors: Jean-Frédéric Colombel
Cancer risk in children with IBD, an under-recognized issueScientific Programme
Year: 2019
Authors: Arie Levine
Complications secondary to intravenous iron infusion in PIBD patient4th D-ECCO Workshop
Year: 2019
Authors: Richard Russell
Crohn’s and the Black death: an evolutionary balance?JCC Podcast
Year: 2019
Authors: Jean-Pierre Hugot et al.

Prof Jean-Pierre Hugot describes his team’s work examining associations between contemporary frequency of NOD2 mutations in populations and estimated rates of death from the plague during the medieval period.

https://academic.oup.com/ecco-jcc/pages/podcast

Keywords:

Crohn’s Disease,
Genetic factors.

Development of an inflammatory bowel disease specific nutrition screening tool (IBD-NST)4th D-ECCO Workshop
Year: 2019
Authors: Catherine Wall
Diet and microbiome in IBD4th D-ECCO Workshop
Year: 2019
Authors: Marjo Campmans-Kuijpers
Distinct IL-13 subgroups in patients with ulcerative colitisJCC Podcast
Year: 2019
Authors: Monica Boirivant et al.

Monica Boirivant describes the work and the thinking behind her team’s demonstration of distinct subgroups of patients with different IL-13 expression in ulcerative colitis, with distinct clinical and microbial profiles and discusses implications for therapeutics in the context of previous negative anti-IL13 studies.

Diverting stoma is enough!8th S-ECCO IBD Masterclass
Year: 2019
Authors: Dieter Hahnloser
Early Surgery in Ileal CD (localised)Transatlantic Talking Heads
Year: 2019
Authors: Fabrizio Michelassi, Peter Irving, Willem Bemelman
ECCO Lecture: Inflammatory Cytokines from Discoveries to TherapiesScientific Programme
Year: 2019
Authors: Charles Dinarello
ECCO RevolutionTalking Heads
Year: 2019
Authors: Renzo Cabrilli, Boris Vucelic, Miquel Gassull
Elastography and CEUS to characterize strictures and abdominal masses in Crohn’s Disease6th ECCO-ESGAR Ultrasound Workshop - Advanced
Year: 2019
Authors: Rune Wilkens
Endoscopic outcomes and therapeutic drug monitoring with Vedolizumab: the Leuven experienceJCC Podcast
Year: 2019
Authors: Bram Verstock et al.

Bram Verstockt reports a large, single centre experience of Vedolizumab use in both UC and CD from Leuven, Belgium with interesting findings for endoscopic outcomes as well as therapeutic drug monitoring.

Faecal calprotectin thresholds to uncover mucosal inflammation in patients with clinically quiescent UCJCC Podcast
Year: 2019
Authors: Lara Hart et al.

Lara Hart discusses her team’s work capturing faecal calprotectin values in a large cohort of patients with clinically quiescent ulcerative colitis undergoing colonoscopy, and reports test performance for predicting ongoing endoscopic or histologic disease activity.